Reference [1] [Bone Tumour Group of the Chinese Orthopaedic Association(2009)] Expert consensus on the surgical treatment of bone metastases.

SKB107 is the first company RDC drug clinical project. About Bone Metastasis of Malignant Tumors Bone is the most common site of metastasis in advanced malignant tumors, and about 70%~80% of ...

SKB107 is the first company RDC drug clinical project. About Bone Metastasis of Malignant Tumors Bone is the most common site of metastasis in advanced malignant tumors, and about 70%~80% of patients ...

Biotech’s radionuclide-drug conjugate SKB107 receives China NMPA approval to treat bone metastases in solid tumours: Chengdu, China Friday, March 28, 2025, 15:00 H ...

as these lesions are frequently under-detected due to the large volume of images to be analyzed and the complexity of bone structures. Despite technological advances in medical imaging, studies show ...

Scientists are looking for answers about how these confounding trips, known as metastases, occur throughout the human body ...

The prognosis of metastatic breast cancer varies based on the site of the tumors. Of the types of metastasis, bone metastasis has the best prognosis, while visceral and brain metastasis have the ...

Long-term opioid use was common among patients with metastatic disease who were at the end of life, but earlier initiation of long-term use had some benefits.

The fourth pair of denosumab biosimilars, Conexxence and Bomyntra, are expected to launch in the United States in mid 2025, ...

FDA expands Pluvicto indication to adults with PSMA+ metastatic castration-resistant prostate cancer previously treated with ...

Vepdegestrant (ARV-471) yielded a statistically significant and clinically meaningful improvement in progression-free ...